| Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma D Sturm, H Witt, V Hovestadt, DA Khuong-Quang, DTW Jones, ... Cancer cell 22 (4), 425-437, 2012 | 1946 | 2012 |
| Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups KW Pajtler, H Witt, M Sill, DTW Jones, V Hovestadt, F Kratochwil, K Wani, ... Cancer cell 27 (5), 728-743, 2015 | 1085 | 2015 |
| Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations P Buczkowicz, C Hoeman, P Rakopoulos, S Pajovic, L Letourneau, ... Nature genetics 46 (5), 451-456, 2014 | 622 | 2014 |
| Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of diffuse intrinsic pontine glioma (DIPG): a collaborative report from the International … LM Hoffman, SEM Veldhuijzen van Zanten, N Colditz, J Baugh, B Chaney, ... Journal of clinical oncology 36 (19), 1963-1972, 2018 | 323 | 2018 |
| The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants KW Pajtler, SC Mack, V Ramaswamy, CA Smith, H Witt, A Smith, ... Acta neuropathologica 133, 5-12, 2017 | 305 | 2017 |
| Therapeutic and prognostic implications of BRAF V600E in pediatric low-grade gliomas A Lassaletta, M Zapotocky, M Mistry, V Ramaswamy, M Honnorat, ... Journal of Clinical Oncology 35 (25), 2934-2941, 2017 | 293 | 2017 |
| Epithelioid GBMs show a high percentage of BRAF V600E mutation BK Kleinschmidt-DeMasters, DL Aisner, DK Birks, NK Foreman The American journal of surgical pathology 37 (5), 685-698, 2013 | 283 | 2013 |
| Autophagy Inhibition Improves Chemosensitivity in BRAFV600E Brain Tumors JMM Levy, JC Thompson, AM Griesinger, V Amani, AM Donson, DK Birks, ... Cancer discovery 4 (7), 773-780, 2014 | 244 | 2014 |
| Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma E Bouffet, R Jakacki, S Goldman, D Hargrave, C Hawkins, M Shroff, ... Journal of clinical oncology 30 (12), 1358-1363, 2012 | 227 | 2012 |
| Integrated (epi)-genomic analyses identify subgroup-specific therapeutic targets in CNS rhabdoid tumors J Torchia, B Golbourn, S Feng, KC Ho, P Sin-Chan, A Vasiljevic, ... Cancer cell 30 (6), 891-908, 2016 | 224 | 2016 |
| MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma AM Donson, SO Addo‐Yobo, MH Handler, L Gore, NK Foreman Pediatric blood & cancer 48 (4), 403-407, 2007 | 224 | 2007 |
| Characterization of distinct immunophenotypes across pediatric brain tumor types AM Griesinger, DK Birks, AM Donson, V Amani, LM Hoffman, A Waziri, ... The Journal of Immunology 191 (9), 4880-4888, 2013 | 223 | 2013 |
| MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence S Venkataraman, I Alimova, R Fan, P Harris, N Foreman, R Vibhakar PloS one 5 (6), e10748, 2010 | 205 | 2010 |
| Creative arts therapy improves quality of life for pediatric brain tumor patients receiving outpatient chemotherapy JR Madden, P Mowry, D Gao, P McGuire Cullen, NK Foreman Journal of Pediatric Oncology Nursing 27 (3), 133-145, 2010 | 195 | 2010 |
| Conformal radiation therapy for pediatric ependymoma, chemotherapy for incompletely resected ependymoma, and observation for completely resected, supratentorial ependymoma TE Merchant, AE Bendel, ND Sabin, PC Burger, DW Shaw, E Chang, ... Journal of clinical oncology 37 (12), 974, 2019 | 183 | 2019 |
| Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors JM Mulcahy Levy, S Zahedi, AM Griesinger, A Morin, KD Davies, ... Elife 6, e19671, 2017 | 173 | 2017 |
| Inhibition of Mer and Axl receptor tyrosine kinases in astrocytoma cells leads to increased apoptosis and improved chemosensitivity AK Keating, GK Kim, AE Jones, AM Donson, K Ware, JM Mulcahy, ... Molecular cancer therapeutics 9 (5), 1298-1307, 2010 | 171 | 2010 |
| Pediatric low-grade gliomas: implications of the biologic era RJ Packer, S Pfister, E Bouffet, R Avery, P Bandopadhayay, M Bornhorst, ... Neuro-oncology 19 (6), 750-761, 2017 | 154 | 2017 |
| Pediatric low-grade gliomas: next biologically driven steps DTW Jones, MW Kieran, E Bouffet, S Alexandrescu, P Bandopadhayay, ... Neuro-oncology 20 (2), 160-173, 2018 | 143 | 2018 |
| Brainstem ganglioglioma successfully treated with vemurafenib. S Rush, N Foreman, A Liu Journal of clinical oncology: official journal of the American Society of …, 2013 | 143 | 2013 |
